_Blog

EudraVigilance: The European system supporting medicines safety

Read more »

October 20, 2026

_Blog

The French Anti-Gift Law decoded

Read more »

October 15, 2026

_Blog

Developing an innovative health product: when and why contact the ANSM GIO?

Read more »

October 15, 2026

_Blog

Environmental Risk Assessment: Balancing Regulatory Requirements, European Developments, and the Need for Scientific Justification

Read more »

September 30, 2026

_Blog

What Are the Role and Responsibilities of a Community Pharmacist in France?

Read more »

September 30, 2026

_Blog

Regulatory Intelligence in the Pharmaceutical Industry: A Strategic Imperative to Anticipate Rather Than React

Read more »

September 30, 2026

_Blog

Food Additive or Pharmaceutical Excipient: One Substance, Two Distinct Regulatory Frameworks

Read more »

September 29, 2026

_Blog

French Good Pharmacovigilance Practices (BPPV)

Read more »

September 2, 2026

_Blog

Pharmaceutical Taxes and Contributions: A Regulatory Maze That Companies Should Not Navigate Alone

Read more »

July 30, 2026

_Blog

Convention unique” in Hospital-Based Clinical Trials: What Are the Obligations for Sponsors in France?

Read more »

July 30, 2026

_Blog

Well-established use legal basis – Article 10(a)

Read more »

July 29, 2026

_Blog

What is eCTD v4.0?

Read more »

April 17, 2026